← Back to headlines
Pfizer and Zai Lab Secure China Approval for Cervical Cancer Therapy Tivdak
Pfizer and Zai Lab have received approval from Chinese authorities for Tivdak, their cervical cancer therapy, expanding its market reach.
9 Jun, 11:30 — 9 Jun, 11:30
Sources
Showing 1 of 1 sources
Related Stories
Bank of Korea Raises Interest Rate to 3 Percent Amid Growth Upgrade
15m ago
Nvidia in Talks to Acquire AI Platform Hugging Face for Over $13 Billion
26m ago
Meta Reaches Up to $18 Billion Settlement in Teen Social Media Addiction Lawsuit
30m ago
Mesoblast Reports Strong Revenue Growth Amid Commercial Transition
40m ago